PE Ratio
34.38
₹586.80 -6.65 (-1.12%)
As on October 30, 2026
6.29%
1 Y CAGR
14,258
CR
Market Cap
Company profile
Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.039
Dividend Yield
0.38%
Sector PE
45.40
Sector ROE
14.06%
Sector Dividend Yield
1.65%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹35.1KCAGR 5-Year
+20.51%Peers & Comparison
BHARTIARTL
Bharti Airtel Ltd
Market cap: ₹11,04,820.39 Cr
ETERNAL
Eternal Ltd
Market cap: ₹2,96,735.94 Cr
DMART
Avenue Supermarts Ltd
Market cap: ₹2,47,038.16 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
